Case report: Successful combination therapy with double-filtration plasmapheresis and rituximab under the condition of the use of a sensor-augmented pump for type B insulin resistance syndrome

Type B insulin resistance syndrome (TBIR) is a rare disease characterized by refractory diabetes due to severe insulin resistance caused by anti-insulin receptor autoantibodies, and a standard treatment regimen for TBIR has not been established, leading to therapeutic difficulties and high mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Osanami, Arata, Kanda, Masatoshi, Sato, Tatsuya, Akazawa, Chikako, Baba, Shuhei, Komatsu, Hiroaki, Murase, Kazuyuki, Yamashita, Tomohisa, Yano, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500182/
https://www.ncbi.nlm.nih.gov/pubmed/36157458
http://dx.doi.org/10.3389/fendo.2022.997296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500182/
https://www.ncbi.nlm.nih.gov/pubmed/36157458
http://dx.doi.org/10.3389/fendo.2022.997296

Ejemplares similares